secwatch / observer
8-K filed September 16, 2022, 7:59 PM ET ticker KPRX CIK 0001372514
leadership confidence high sentiment neutral materiality 0.60

Kiora Pharmaceuticals names Melissa Tosca EVP of Finance; shareholders approve warrant share issuance

KIORA PHARMACEUTICALS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Melissa Tosca

Executive Vice President of Finance
KPRX · KIORA PHARMACEUTICALS INC
Effective
2022-09-13
Filed
September 16, 2022, 7:59 PM ET
On September 13, 2022 (the “Effective Date”), Kiora Pharmaceuticals Inc. (the “Company”) appointed Melissa Tosca as Executive Vice President of Finance of the Company, effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Melissa Tosca was appointed as Executive Vice President of Finance at KIORA PHARMACEUTICALS INC.

Action
appointed
Role
Executive Vice President of Finance
Exact text from the filing
On September 13, 2022 (the “Effective Date”), Kiora Pharmaceuticals Inc. (the “Company”) appointed Melissa Tosca as Executive Vice President of Finance of the Company, effective as of the Effective Date.
View on SEC.gov

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR
accession 0001104659-22-100852
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.